Status:
COMPLETED
THRIVE Ventilation for Operative Hysteroscopy Under General Anesthesia
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Oxygen
General Anesthesia
Eligibility:
FEMALE
18-70 years
Brief Summary
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) allows to extend the apnoeic window in patients undergoing general anesthesia by delivering 100% of heated and humidified oxygen ...
Detailed Description
Background Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE), term coined by Patel and Nouraei, refers to a technique that allows to extend the apnoeic window in patients undergoi...
Eligibility Criteria
Inclusion
- ASA I-II.
Exclusion
- BMI \> 30,
- pregnancy,
- cardiac arrhythmia,
- high risk of aspiration,
- neuromuscular disease,
- patient refusal.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05291117
Start Date
February 1 2022
End Date
May 1 2022
Last Update
May 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico Agostino Gemelli
Rome, Italy, 00168